Radiofrequency ablation with or without transcatheter chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol 2013; 31: 426-432.

Published: 20th June 2013

Authors: Peng Z-W, Zhang Y-J, Chen M-S, Xu L, Lian H-L, Lin X-J et al. et al.

Conclusion

In this study that included 189 patients with tumours less than 7cm in diameter followed for up to 62 months, the combined treatment had improved overall survival (hazard ratio 0.52, 95 per cent confidence interval0.33 to 0.82, P=0.002) and recurrence-free survival (0.575, 0.37 to 0.09, P=0.009).

Pubmed Link

Your comments

0 Comments